UK markets closed
NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.63 +0.15 (+0.19%) GOLD FUTURES
2,323.10 -8.10 (-0.35%) DOW
38,847.91 -4.36 (-0.01%) Bitcoin GBP
50,528.73 +76.47 (+0.15%)
Summit Therapeutics plc (SMMT)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 02:31PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 3.14B |
| Enterprise value | 3.09B |
| Trailing P/E | 11.76 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 70.98 |
| Enterprise value/revenue | 6.43k |
| Enterprise value/EBITDA | -30.07 |
Trading information
Stock price history
| Beta (5Y monthly) | -1.20 |
| 52-week change 3 | 132.81% |
| S&P500 52-week change 3 | 25.77% |
| 52-week high 3 | 5.30 |
| 52-week low 3 | 1.50 |
| 50-day moving average 3 | 4.05 |
| 200-day moving average 3 | 2.82 |
Share statistics
| Avg vol (3-month) 3 | 2.22M |
| Avg vol (10-day) 3 | 2.09M |
| Shares outstanding 5 | 701.98M |
| Implied shares outstanding 6 | 701.98M |
| Float 8 | 73.32M |
| % held by insiders 1 | 88.12% |
| % held by institutions 1 | 4.89% |
| Shares short (15 Apr 2024) 4 | 22.9M |
| Short ratio (15 Apr 2024) 4 | 8.66 |
| Short % of float (15 Apr 2024) 4 | 27.41% |
| Short % of shares outstanding (15 Apr 2024) 4 | 3.26% |
| Shares short (prior month 15 Mar 2024) 4 | 16.96M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -33.27% |
| Return on equity (ttm) | -130.59% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -114.75M |
| Net income avi to common (ttm) | -116.03M |
| Diluted EPS (ttm) | 0.38 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 156.68M |
| Total cash per share (mrq) | 0.22 |
| Total debt (mrq) | 109.52M |
| Total debt/equity (mrq) | 247.73% |
| Current ratio (mrq) | 6.97 |
| Book value per share (mrq) | 0.06 |
Cash flow statement
| Operating cash flow (ttm) | -93.76M |
| Levered free cash flow (ttm) | -527.61M |
© 2024 Yahoo. All rights reserved.